NewLimit raised $435M in Series C funding led by Founders Fund to advance its first age-reprogramming drug into human trials.News, Brian Armstrong, CoinbaseRead More

You might also be interested in reading FHLBank Atlanta Contributes Nearly $6 Million to Help Homeowners Safeguard their Inheritances.